Abbott Making 50,000 COVID-19 Tests Daily

It's about the size of a toaster.

 

On Wednesday, Abbott Labs will start making 50,000 COVID-19 tests per day. The company's plant in Scarborough, Maine plans to make more than 1 million tests per month.  

The point-of-care test is built off of the company's ID Now product that tests for the flu and strep throat.  

According to the company, the new ID NOW COVID-19 test can provides a negative result in 13 minutes, and a positive result in five minutes. Abbott says it's the fastest available molecular point-of-care test for COVID-19. 

The FDA gave Abbott emergency authorization to make the test.  

The ID NOW COVID-19 test weighs 6.6 pounds and is about the size of a toaster, which means it can be used in non-traditional places to give people their results in a matter of minutes.

Testing is a crucial step in controlling the novel COVID-19 pandemic, and curbing the spread of infection. 

Molecular testing technologies help detect the presence of a virus by identifying a small section of the virus' genome, then amplifying that portion until there's enough for detection. 

The ID NOW COVID-19 EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories and patient care settings. 

Latest in Operations
More in Operations